...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Eversana ValuationCaseStudy

"Why it's not happening is the million dollar question"

Do we need cash to incentivize participation? But how do you negotiate with participants in a hospitalized setting when time is of the essence in a life and death Covid-19 situation? 

Would it have been any easier in a non hospitalized setting? This is how the University of Minnesota went about it. Wondering if Pfizer's took the same approach for their double-blind non hospitalized study. 

https://www.parsemus.org/humanhealth/covid-19/covid-out-uminn/?gclid=EAIaIQobChMI7Y3Yn4qi9QIVcRFMCh3oJQ-vEAAYASAAEgI2G_D_BwE


Koo

Share
New Message
Please login to post a reply